Person:
Rangachari, Manu V.

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Rangachari

First Name

Manu V.

Name

Rangachari, Manu V.
Author's Publications: search.filters.isAuthorOfPublication.bbfbe631-7d0c-4cec-a801-d76bfbf371e3

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Publication
    A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C Infection
    (Public Library of Science, 2010) Mengshol, John A.; Golden-Mason, Lucy; Arikawa, Tomohiro; Smith, Maxwell; Niki, Toshiro; McWilliams, Ryan; Randall, Jessica A.; McMahan, Rachel; Zimmerman, Michael A.; Dobrinskikh, Evgenia; Busson, Pierre; Polyak, Stephen J.; Hirashima, Mitsuomi; Rosen, Hugo R.; Rangachari, Manu V.
    Approximately 200 million people throughout the world are infected with hepatitis C virus (HCV). One of the most striking features of HCV infection is its high propensity to establish persistence (∼70–80%) and progressive liver injury. Galectins are evolutionarily conserved glycan-binding proteins with diverse roles in innate and adaptive immune responses. Here, we demonstrate that galectin-9, the natural ligand for the T cell immunoglobulin domain and mucin domain protein 3 (Tim-3), circulates at very high levels in the serum and its hepatic expression (particularly on Kupffer cells) is significantly increased in patients with chronic HCV as compared to normal controls. Galectin-9 production from monocytes and macrophages is induced by IFN-γ, which has been shown to be elevated in chronic HCV infection. In turn, galectin-9 induces pro-inflammatory cytokines in liver-derived and peripheral mononuclear cells; galectin-9 also induces anti-inflammatory cytokines from peripheral but not hepatic mononuclear cells. Galectin-9 results in expansion of CD4+CD25+FoxP3+CD127low regulatory T cells, contraction of CD4+ effector T cells, and apoptosis of HCV-specific CTLs. In conclusion, galectin-9 production by Kupffer cells links the innate and adaptive immune response, providing a potential novel immunotherapeutic target in this common viral infection.